Health Care • Hospital/Nursing Management
$34.25 ▲ +0.65
(+1.94%)
MKT CAP: $1.65B • VOL: 392.7K
52W L $25 52W H $44
ROARABLE / RQD
D • 45/100
PIOTROSKI
3 / 9
SNDA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $381.1M | $304.3M | $255.3M |
| YoY Revenue Growth % | +25.2% | +19.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $68.7M | $57.9M |
| Operating Margin % | — | 22.6% | 22.7% |
| Net Income (GAAP) | -$72.5M | -$3.3M | -$21.1M |
| EBITDA (Normalized) | — | $88.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $24.4M | -$1.8M | $10.7M |
| Capital Expenditures (CapEx) | $33.3M | $25.2M | — |
| Free Cash Flow (FCF) | -$8.9M | -$27.0M | $10.7M |
| FCF Margin % | -2.3% | -8.9% | 4.2% |
| Return on Invested Capital (ROIC %) | — | 7.9% | — |
| Cash & Short-Term Equivalents | $11.0M | $17.0M | — |
| Total Debt (Short + Long Term) | $682.5M | $635.9M | — |
| Total Stockholders' Equity | -$11.0K | $71.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SNDA.